News

ViennaLab Diagnostics is part of the HUFIAT Consortium awarded a contract for Phase 1 to develop an end-to-end NGS solution in the field of liquid biopsy (cfDNA).

ViennaLab Diagnostics will apply their expertise in cfDNA and genetic tests and join forces with bioinformatics experts – Euformatics and AI specialists – Oncompass Medicine to work on a solution which aims to improve the field of liquid biopsy and cancer detection.

With this non-invasive approach we will develop a Pan-cancer cfDNA test to profile the tumor landscape which will allow to predict the best personalized treatment for every patient.

Follow the link to get more information on OncNGS . Please click here for the official Press Release.

Medlab Middle East 2023 is taking place as usual!

The live event will be held from February 6 - 9, 2023.

Dubai World Trade Centre

ViennaLab is exhibiting together with our mother company, BioVendor, at booth Z5.D30 and in parallel with HVD VertriebsGmbH at booth Z5.C20.

We are looking forward to your visit!

Check out our improved 16S Microbiome NGS Assay

We now offer an improved version of our NGS Assay with a more easier and even faster library preparation protocol bundled with data analysis for accurate species level-classification.

Improvements:

• Fast and optimized 2-step protocol minimizes set-up time
• More balanced heterogeneity spacers to enhance library complexity for improved sequencing quality
• Elimination of PhiX spike-in results in lower reagent expenses, more samples per sequencing run and therefore lower costs per sample

For more detailed information follow this link.

Thank you!

This year is coming to an end and thus we want to use this opportunity to thank our business partners, customers and distribution partners for your trust in us.

We wish you and your family happy holidays and a prosperous New Year!

ViennaLab Team

Visit us at MEDICA 2022

The live event will be held from November 14 - 17, 2022 and we will be on site.

Messe Düsseldorf, GERMANY

We are exhibiting together with our mother company, BioVendor, in Hall 3 A92.

We are really looking forward to meet with you again in person!

ViennaLab Diagnostics is part of the MedPhab consortium funded by a Horizon 2020 research grant.

MedPhab serves as Europe’s first Pilot Line dedicated to manufacturing, testing, validation and up-scaling of new photonics technologies for medical diagnostics. The purpose of MedPhab pilot production line is to accelerate the commercialisation of diagnostic devices and instruments for treatment based on photonics, and to reduce the R&D costs. pdf Read more .

Medphab is launching an Open Call for external companies developing medical products. pdf Read more .

12th European Meeting on Molecular Diagnostics 2022

The live event will be held from October 12 - 14, 2022.

Grand Hotel Huis ter Duin

ViennaLab is represented by our local distribution partner, Goffin Molecular Technologies. You find us at booth 26.

We are looking forward to your visit!

Explore the full power of NGS

At the beginning of July we launched our NGS Assays which provide the next level of variant analysis by Next Generation Sequencing (NGS).

• Hereditary Cancer NGS Assay
• Somatic Mutations NGS Assay
• Clinical Exome Sequencing (CES) NGS Assay

We provide our customers an all-in-one solution, comprising library preparation, bioinformatic analysis via Genovesa and genetic variant report generation.

Interested to learn more about the features? Contact This email address is being protected from spambots. You need JavaScript enabled to view it..

European Society of Human Genetics 2022 Conference is taking place as usual - LIVE!

The live event will be held from June 11 - 14, 2022.

Austria Center Vienna

ViennaLab is exhibiting together with our mother company, BioVendor, at booth X5-234.

We are looking forward to your visit!

Österreichische Gesellschaft für Klinische Pathologie und Molekularpathologie / Österreichische Abteilung der Internationalen Akademie für Pathologie (ÖGPath/IAP Austria)

Die Frühjahrstagung findet vom 11. bis 12. März 2022 in persona statt.

TechGate Vienna, Donau City Wien

ViennaLab wird abermals vom österreichischen Vertriebspartner HVD Life Science Vertriebs GmbH bei der Industrieausstellung vertreten.

Wir freuen uns auf Ihren Besuch auf unserem Messestand!

Medlab Middle East 2022 is taking place as usual - Back to business in person!

The live event will be held from January 24 - 27, 2022.

Dubai World Trade Centre

ViennaLab is exhibiting together with our mother company, BioVendor, at booth Z5.D30 and in parallel with HVD VertriebsGmbH at booth Z5.D20.

We are looking forward to your visit!

BioVendor is changing its face!

Introducing the new BioVendor Group identity!

BioVendor Group is growing. Since its foundation in 1992, the original small company has been transformed into a multinational group supported by its own R&D division. It includes the established brands BioVendor R&D, TestLine, DiaSource, ViennaLab and Oxford BioSystems.

Please click here to read more about the pdf press release .